Dr. Michelle Longmire is the founder and Chief Executive Officer of Medable. Dr. Longmire is mission driven to accelerate the development of new therapies for disease. As a Stanford-trained physician-scientist, Dr. Longmire identified critical barriers to drug development and founded Medable to pioneer a new category of clinical trial technologies that remove traditional roadblocks to participation and radically accelerate the research process. Medable is now the industry leader in decentralized and direct-to-patient research, serving patients in clinical trials in over 30 languages, 40 countries, and across all therapeutic areas. In addition to having raised over 40 million dollars in venture capital and driving Medable to an industry-leading position, Dr. Longmire has received recognition as a leading innovator and business woman, including being named as one of the 100 most creative people in business by Fast Company.
Speaking In
11:00 AM - 12:00 PM (PDT)
Wednesday, October 14
With more than 75% of clinical trials disrupted due to the COVID-19 pandemic, many biopharma…